Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" Study (PRONE)
Primary Purpose
Covid19, Pneumonia, Viral
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Prone Positioning
Sponsored by
About this trial
This is an interventional treatment trial for Covid19 focused on measuring covid19, pneumonia, prone positioning, COVID
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18 years
- COVID-19 positive by nasopharyngeal swab or serostatus
- Use of supplemental oxygen OR respiratory rate ≥ 20
Exclusion Criteria:
- BMI ≥ 45 kg/m2
- Pregnancy
- Chest tube placement
- Hemodynamic instability with mean arterial pressure < 60 mmHg
- Thoracic or abdominal wounds
- Chest wall deformities
- Vertebral column deformities that would preclude prone positioning
- Facial trauma or surgery in the last 30 days
- Established diagnosis of interstitial lung disease
- Prior single or double lung transplant
- Surgery for spine, femur, or pelvis in the last 3 months
- Thoracic or cardiac surgery in the last 30 days
- Pacemaker placement last 7 days
Sites / Locations
- Johns Hopkins Univeristy
- University of North Carolina
- Duke University
- UPMC
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Control - Usual Care
Intervention - Prone Positioning
Arm Description
Usual Care
Prone Positioning
Outcomes
Primary Outcome Measures
Occurrence of an escalation in respiratory related care (yes vs no)
Participants will be assessed for the occurrence of an escalation in respiratory related care (Yes or No). Escalation in respiratory related care is clinically defined as any of the following:
intubation
any increase in flow of supplemental oxygen
transition to high flow nasal cannula
increase in fraction of inspired oxygen
transfer from a lower to a higher level acuity of care (e.g. medical floor to intermediate care unit (IMC) or intensive care unit (ICU); IMC to ICU).
Secondary Outcome Measures
Oxygen Saturation
Oxygen Saturation measured in percent oxygen over a 24-hour period.
Respiratory Effort as assessed by Respiratory Rate
Respiratory effort will be assessed using the respiratory rate (in breaths per minute) over a 24-hour period.
Full Information
NCT ID
NCT04517123
First Posted
August 14, 2020
Last Updated
January 12, 2022
Sponsor
Johns Hopkins University
Collaborators
Duke University, University of North Carolina, University of Miami, University of Pittsburgh, Smith & Nephew, Inc., Nox Medical Iceland
1. Study Identification
Unique Protocol Identification Number
NCT04517123
Brief Title
Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" Study
Acronym
PRONE
Official Title
Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
September 1, 2020 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
December 31, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
Duke University, University of North Carolina, University of Miami, University of Pittsburgh, Smith & Nephew, Inc., Nox Medical Iceland
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The overall objective of this study is to determine whether a positional maneuver (e.g., prone positioning) decreases the need for escalation of respiratory-related care in patients with coronavirus (COVID-19) pneumonia.
Detailed Description
As the initial outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes, coronavirus disease 2019 (COVID-19) has spread beyond Wuhan, China it has become a pandemic affecting over 178 countries. Of patients admitted to the ICU, upwards of 85% developed the acute respiratory distress syndrome (ARDS) and most if not all required mechanical ventilation. The beneficial effects of prone positioning for ARDS have been well described. Coupling the reported benefits of prone positioning in COVID-19 associated ARDS patients with the known beneficial effects of early prone-positioning in the treatment of ARDS, it is not surprising that many hospital systems are advocating prone positioning for treatment of ARDS in patients with COVID-19. However, as the pandemic continues to progress in the United States and the number of new cases grows as new clusters emerge, the possibility of 'rationing' ventilators becomes more real. Therefore, therapies that prevent the need for mechanical ventilation are desperately needed. Given the distinct benefit that patients with COVID-19 have with prone positioning, the overarching hypothesis of this trial is that patients with high risk for respiratory failure may also benefit from prone positioning.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Covid19, Pneumonia, Viral
Keywords
covid19, pneumonia, prone positioning, COVID
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
35 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control - Usual Care
Arm Type
No Intervention
Arm Description
Usual Care
Arm Title
Intervention - Prone Positioning
Arm Type
Experimental
Arm Description
Prone Positioning
Intervention Type
Other
Intervention Name(s)
Prone Positioning
Intervention Description
Prone Positioning
Primary Outcome Measure Information:
Title
Occurrence of an escalation in respiratory related care (yes vs no)
Description
Participants will be assessed for the occurrence of an escalation in respiratory related care (Yes or No). Escalation in respiratory related care is clinically defined as any of the following:
intubation
any increase in flow of supplemental oxygen
transition to high flow nasal cannula
increase in fraction of inspired oxygen
transfer from a lower to a higher level acuity of care (e.g. medical floor to intermediate care unit (IMC) or intensive care unit (ICU); IMC to ICU).
Time Frame
During hospitalization, up to 30 days
Secondary Outcome Measure Information:
Title
Oxygen Saturation
Description
Oxygen Saturation measured in percent oxygen over a 24-hour period.
Time Frame
Over a consecutive 24-hour period after randomization
Title
Respiratory Effort as assessed by Respiratory Rate
Description
Respiratory effort will be assessed using the respiratory rate (in breaths per minute) over a 24-hour period.
Time Frame
Over a consecutive 24-hour period after randomization
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age ≥ 18 years
COVID-19 positive by nasopharyngeal swab or serostatus
Use of supplemental oxygen OR respiratory rate ≥ 20
Exclusion Criteria:
BMI ≥ 45 kg/m2
Pregnancy
Chest tube placement
Hemodynamic instability with mean arterial pressure < 60 mmHg
Thoracic or abdominal wounds
Chest wall deformities
Vertebral column deformities that would preclude prone positioning
Facial trauma or surgery in the last 30 days
Established diagnosis of interstitial lung disease
Prior single or double lung transplant
Surgery for spine, femur, or pelvis in the last 3 months
Thoracic or cardiac surgery in the last 30 days
Pacemaker placement last 7 days
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Naresh Punjabi, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins Univeristy
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21287
Country
United States
Facility Name
University of North Carolina
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27514
Country
United States
Facility Name
Duke University
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States
Facility Name
UPMC
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" Study
We'll reach out to this number within 24 hrs